Grifols, S.A. (GRF) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 59
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G15C6446B05EN
Leaflet:

Download PDF Leaflet

Grifols, S.A. (GRF) - Medical Equipment - Deals and Alliances Profile
Summary

Grifols, S.A. (Grifols) is a pharmaceutical and chemical company focused at improving the health and well being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, diagnostic products and hospital pharmacy products. It produces plasma derived protein therapies for patients suffering with rare, genetic diseases and life-threatening infections. Grifols has plasma donation centers across the US and industrial facilities in Australia, Mexico, Switzerland, the US and Spain. It established a system that carries out operations from collecting source plasma to the fractionation, purification and production of the finished product. Grifols is headquartered in Sant Cugat del Valles, Barcelona, Spain.

Grifols, S.A. (GRF) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment Deals By Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Region, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Market, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals Summary, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deal Details
Asset Purchase
Grifols Acquires Blood Transfusion Diagnostics Business from Novartis for USD1.66 Billion
Partnerships
Singulex Enters into Licensing Agreement with Grifols
Grifols Enters Into Distribution Agreement With Kainos Labs
Health Robotics Enters Into Co-Marketing Agreement With Grifols
Grifols Enters Into Co-Marketing Agreement With Novartis
Progenika Biopharma Enters Into An Agreement With Grifols
Equity Offering
Grifols Invests USD50 Million in Singulex
TiGenix Completes Private Placement Of Shares For US$16.2 Million
Debt Offering
Grifols Completes Public Offering Of Bonds Due 2022 For US$1 Billion
Acquisition
Grifols Acquires Additional 32.93% Stake in Progenika Biopharma for USD27 Million
Grifols Acquires 50% Stake in Kiro Robotics for USD27 Million
Alken Asset Management Sells 2.72% Stake In Grifols For US$227 Million
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million
Grifols Acquires 60% Stake In Progenika Biopharma For US$48 Million
Grifols Acquires Remaining 51% Stake In Lateral-Medion
Diagnostic Grifols Sells 35% Stake In Quest International, Regents and Analysis Instruments Manufacturer
Grifols, S.A. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Jun 30, 2015: ISD completes single envelope ‘clad rack’ cold storage facility for Spanish pharmaceutical giant Grifols
Financial Announcements
May 05, 2016: Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division
Feb 29, 2016: Grifols' revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million
Feb 26, 2015: Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014
Corporate Communications
Dec 14, 2015: Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company
Legal and Regulatory
Feb 16, 2015: Grifols PhocusRx Certified DIACAP Compliant
Jan 21, 2015: Grifols Academy of Plasmapheresis Awarded ACCET Accreditation
Jan 02, 2015: Grifols new immunoglobulin purification plant in the United States receives FDA approval
Other Significant Developments
Jul 05, 2016: Pedigri: the tool that increases the information transparency to the plasma-derived manufactured in Clayton
Jun 16, 2016: Grifols confirms that it has voluntarily signed the EFPIA Code of Conduct
Mar 03, 2016: Grifols: The company doesn´t have any tax litigation in any country where it operates
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Grifols, S.A., Medical Equipment, Key Facts, 2015
Grifols, S.A., Medical Equipment, Deals Summary, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment Deals By Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Region, 2010 to YTD 2016
Grifols, S.A., Deals By Market, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals Summary, 2010 to YTD 2016
Grifols Acquires Blood Transfusion Diagnostics Business from Novartis for USD1.66 Billion
Singulex Enters into Licensing Agreement with Grifols
Grifols Enters Into Distribution Agreement With Kainos Labs
Health Robotics Enters Into Co-Marketing Agreement With Grifols
Grifols Enters Into Co-Marketing Agreement With Novartis
Progenika Biopharma Enters Into An Agreement With Grifols
Grifols Invests USD50 Million in Singulex
TiGenix Completes Private Placement Of Shares For US$16.2 Million
Grifols Completes Public Offering Of Bonds Due 2022 For US$1 Billion
Grifols Acquires Additional 32.93% Stake in Progenika Biopharma for USD27 Million
Grifols Acquires 50% Stake in Kiro Robotics for USD27 Million
Alken Asset Management Sells 2.72% Stake In Grifols For US$227 Million
Grifols Completes Acquisition Of 35% Stake In Aradigm For US$26 Million
Grifols Acquires 60% Stake In Progenika Biopharma For US$48 Million
Grifols Acquires Remaining 51% Stake In Lateral-Medion
Diagnostic Grifols Sells 35% Stake In Quest International, Regents and Analysis Instruments Manufacturer
Grifols, S.A., Key Competitors
Grifols, S.A., Key Employees
Grifols, S.A., Other Locations
Grifols, S.A., Subsidiaries

LIST OF FIGURES

Grifols, S.A., Medical Equipment, Deals by Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Region, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Market, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals by Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Region, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Grifols, S.A. (GRF) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: